|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-1.95% | -8.87% |
| 23-11-10 | Alvotech, Stada Get EU Panel Backing for Stelara Biosimilar | MT |
| 23-07-25 | Xbrane Biopharma and Stada consider options for ranibizumab | FW |
More news
More press releases
More news
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 2018-08-31 | |
Boris Döbler
DFI | Director of Finance/CFO | - | 2022-12-31 |
Miguel Fernandez
CTO | Chief Tech/Sci/R&D Officer | 60 | 2014-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jens Steegers
BRD | Director/Board Member | 45 | 2014-06-03 |
Eric Cornut
BRD | Director/Board Member | 68 | 2016-08-25 |
Günter von Au
CHM | Chairman | 74 | 2017-09-26 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -1.95% | - | - | 5.73B | ||
| +0.65% | +0.41% | +0.22% | +81.48% | 47.01B | ||
| +0.53% | -0.92% | +7.23% | +105.04% | 31.32B | ||
| +1.17% | -3.42% | +54.02% | - | 30.63B | ||
| -0.18% | +0.40% | +3.17% | +36.50% | 13.32B | ||
| +0.41% | -0.60% | -5.34% | +124.34% | 10.12B | ||
| -0.55% | -8.04% | +69.76% | +74.02% | 8.9B | ||
| -2.28% | -3.75% | +38.99% | +107.88% | 6.9B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| +0.11% | +0.16% | +34.40% | -35.06% | 6.67B | ||
| Average | -0.01% | -1.32% | +25.31% | +70.60% | 16.74B | |
| Weighted average by Cap. | +0.39% | -1.16% | +19.36% | +80.76% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Equities
- SAZ Stock
Select your edition
All financial news and data tailored to specific country editions
















